对非神经调节器临床医生的神经调节指南:它是什么以及它如何使患者受益?
Chelsey Hoffmann1, Jinlan Wang2, Rushna P Ali3
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Biomolecules & biomedicine
|August 12, 2024
概括
神经调节装置可以治疗各种疾病,但一般性教育却落后. 对可植入神经调节的审查发现,临床医生必须了解这些不断扩展的治疗方法.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 医疗器械 医疗器械
背景情况:
- 神经调节越来越多地用于各种疾病,无论是痛苦的还是非痛苦的.
- 在一般医学期刊中,关于神经调节的出版物很少出现,这限制了临床医生的广泛认识.
- 这种差距凸显出需要在专业领域之外更好地传播神经调节知识.
研究的目的:
- 审查植入式神经调节器械,其FDA批准和非标签指示.
- 评估与这些设备相关的潜在风险和益处.
- 通知医疗专业人员关于神经调节的扩大使用.
主要方法:
- 在PubMed和Medline.com上进行了文献搜索.
- 包括系统性审查,元分析和可植入神经调节装置的随机对照试验.
- 在对106篇出版物进行初步资格选后,最终审查包括了67项研究.
主要成果:
- 该审查涵盖了各种可植入的神经调节器件及其临床应用.
- 综合了FDA批准的指示,非标签用途,风险和益处的信息.
- 该研究发现,神经调节程序的临床体积越来越大.
结论:
- 随着其使用范围的扩大,对神经调节的医学专业人员的教育至关重要.
- 对于所有临床医生来说,对神经调节的基线理解是必要的.
- 预计神经调节将在所有医学子专业中变得越来越普遍.
更多相关视频
09:52Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
Published on: February 23, 2020
9.1K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.8K
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
402
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
402
